Related Experiment Video
Updated: Jul 9, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Polygenic scores in psychiatric research and clinical practice
Leonard Frach1, Friederike S David2, Markus M Nöthen2
1University Hospital Bonn, University of Bonn Institute of Human Genetics Venusberg-Campus 1 53127 Bonn Germany.
None:
Polygenic scores are nowadays common tools in psychiatric genetic research and are also increasingly applied in clinical settings. In this article, we give an overview of polygenic scores in psychiatric research, focusing on recent trends and novel applications such as using polygenic scores in family studies. Furthermore, we discuss use cases of polygenic scores in clinical studies and clinical practice, for instance using polygenic scores to predict treatment response to medication. While some challenges of polygenic scores are not unique to psychiatry (e.g. limited reliability or transferability across ancestries), we also highlight the specialties of using polygenic scores in psychiatric research and clinical practice (e.g. clinical and biological heterogeneity across and within psychiatric conditions), as well as limitations of other applications beyond research, e.g. using polygenic scores for psychiatric conditions for embryo selection. We further make the case for careful communication of genetics to patients and the general public. We conclude by providing an outlook which includes future directions and applications of polygenic scores in psychiatric research and clinical practice.
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Polygenic Traits
Polygenic Traits
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Self-Report Tests of Personality
Pharmacogenomics: Identification of New Drug Targets
